💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

TIMELINE-Key dates in health problems of Apple's Jobs

Published 01/17/2011, 12:18 PM
Updated 01/17/2011, 12:24 PM

Jan 17 (Reuters) - Apple Inc Chief Executive Steve Jobs said on Monday he would take medical leave from work, two years after taking a six-month break during which he underwent a liver transplant.

Here is a chronology of his health issues:

August 2004: Jobs announces he underwent surgery to remove a cancerous tumour from his pancreas. He said it was a rare form of pancreatic cancer called an islet cell neuroendocrine tumour, which often is not quite as deadly as the more common forms of pancreatic cancer. The tumours can cause hormone imbalances.

June 2005: Jobs mentions the cancer in a commencement address at Stanford University.

"This was the closest I have been to facing death, and I hope it is the closest I get for a few more decades," he says.

2008:

June 9: Jobs appears dramatically thinner at an Apple iPhone event, touching off speculation the cancer had returned. The company said he was fighting a "common bug" and taking antibiotics. Apple later called Jobs's health a private matter.

July 26: The New York Times journalist Joe Nocera said in a column he had spoken to Jobs about his health but because the conversation was off record, he could not disclose what was said.

"While his health problems amounted to a good deal more than 'a common bug', they were not life-threatening and he does not have a recurrence of cancer," Nocera wrote.

Sept. 9: At an iPod product launch, Jobs jokes about his health by walking on stage in front of a giant screen that flashed "The reports of my death are greatly exaggerated" -- a quotation borrowed from Mark Twain.

Oct. 3: A false internet report that Jobs had suffered a heart attack briefly pushes Apple shares down 2 percent to a 17-month low. Apple quickly denied the report on iReport.com, a citizen journalist site owned by CNN.

Oct. 14: At a Mac product launch event, Jobs jokes again about his health. His blood pressure was 110 over 70 and he said, "And that is all we are going to be talking about Steve's health today."

Dec. 16: Apple said Jobs would not deliver the keynote address at the Macworld trade show in January, reviving concerns about his health.

Asked to explain the decision, a spokesman said it would be the last time Apple takes part in Macworld so, "it does not make sense for us to make a major investment in a trade show we will no longer be attending."

Dec. 30: Apple shares fall as much as 2 percent after Gizmodo said that Jobs's health was "rapidly declining" and that was the reason why he cancelled the Macworld keynote.

2009:

Jan. 5: Jobs says he has been losing weight throughout 2008 and his doctors think a hormone imbalance is "robbing" him of proteins. He says he has begun a "relatively simple and straightforward" treatment for his nutritional problem and that he will continue as CEO during recovery.

"I will be the first one to step up and tell our board of directors if I can no longer continue to fulfil my duties as Apple's CEO," he says. Apple shares rise 5 percent.

Jan. 14: Jobs announces medical leave until the end of June, saying his health issues are "more complex" than originally thought.

He hands day-to-day operations to Chief Operating Officer Tim Cook and says he plans to remain involved in major strategic decisions. Apple shares fall 10 percent in after-hours trading.

Jan. 21: The U.S. Securities and Exchange Commission is examining Apple's disclosures about Jobs to ensure investors were not mislead, Bloomberg says.

June 8: Apple unveils new iPhone 3GS at its annual Worldwide Developer's Conference, but Jobs does not make an appearance.

June 20: The Wall Street Journal reports that Jobs had a liver transplant in Memphis, Tennessee about two months before and that he is expected to return to work later in June.

June 22: Jobs is spotted at the Apple campus in Cupertino, California, underscoring expectations that he is either back at work or will return soon.

June 23: The Methodist University Hospital Transplant Institute confirms it performed a liver transplant on Jobs and says he is "recovering well and has an excellent prognosis." The hospital does not give more details, saying the confirmation had come with Jobs's permission.

Organ transplant recipients often have recurring health issues for life, in part because they must take immune-suppressing drugs to prevent organ rejection or graft versus host disease.

June 30: Jobs returns to work, an Apple spokesman says. adding that he will work from home part of the time.

2011:

Jan 17: Jobs says he will take medical leave from Apple. Cook will take responsibility for day-to-day operations but Jobs will continue to be chief executive and be involved in major strategic decisions.

"I love Apple so much and hope to be back as soon as I can," the 55-year-old says. Apple shares were down 8.3 percent in Frankfurt by 1503 GMT. Monday was a holiday in the United States and markets were closed there. (Compiled by Kate Holton in London; Editing by Greg Mahlich)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.